Jin Yang Pharmaceutical Co., Ltd. (KOSDAQ:007370)
South Korea
· Delayed Price · Currency is KRW 5,250.00
+100.00 (1.94%)
At close: Dec 5, 2025
Jin Yang Pharmaceutical Revenue
Jin Yang Pharmaceutical had revenue of 29.25B KRW in the quarter ending September 30, 2025, a decrease of -7.50%. This brings the company's revenue in the last twelve months to 117.19B, up 5.81% year-over-year. In the year 2024, Jin Yang Pharmaceutical had annual revenue of 113.33B with 20.94% growth.
Revenue (ttm)
117.19B
Revenue Growth
+5.81%
P/S Ratio
0.54
Revenue / Employee
532.66M
Employees
220
Market Cap
63.18B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 113.33B | 19.62B | 20.94% |
| Dec 31, 2023 | 93.71B | 17.44B | 22.87% |
| Dec 31, 2022 | 76.26B | 13.43B | 21.36% |
| Dec 31, 2021 | 62.84B | 13.31B | 26.88% |
| Dec 31, 2020 | 49.52B | 2.17B | 4.59% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 315.56T |
| SK hynix | 84.09T |
| LG Energy Solution | 23.98T |
| Samsung Biologics | 5,504.84B |
| Hyundai Motor Company | 186.04T |
| Doosan Enerbility | 16.79T |
| HD Hyundai Heavy Industries | 16.39T |
| KB Financial Group | 14.89T |